©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Feb 25, 2016; 8(4): 198-204
Published online Feb 25, 2016. doi: 10.4253/wjge.v8.i4.198
Published online Feb 25, 2016. doi: 10.4253/wjge.v8.i4.198
Role of colonic stents in the management of colorectal cancers
Jayesh Sagar, Department of Surgery, Medway Maritime Hospital, Gillingham ME7 5NY, United Kingdom
Author contributions: Sagar J conceived the issues which formed the contents of the manuscript and wrote the manuscript.
Conflict-of-interest statement: The author has no conflict of interests.
Correspondence to: Dr. Jayesh Sagar, DNB, FRCS (Ed), MD, Surgeon, Department of Surgery, Medway Maritime Hospital, Windmill Rd, Gillingham ME7 5NY, United Kingdom. jsagar_2001@yahoo.com
Telephone: +44-7875-104480
Received: August 14, 2015
Peer-review started: August 22, 2015
First decision: October 13, 2015
Revised: December 7, 2015
Accepted: December 18, 2015
Article in press: December 21, 2015
Published online: February 25, 2016
Processing time: 186 Days and 15 Hours
Peer-review started: August 22, 2015
First decision: October 13, 2015
Revised: December 7, 2015
Accepted: December 18, 2015
Article in press: December 21, 2015
Published online: February 25, 2016
Processing time: 186 Days and 15 Hours
Core Tip
Core tip: Although colonic stents have been used for years to treat acute malignant colonic obstructions, current evidence based on the systematic review and randomised controlled trials do raise concerns about its impact on the long term outcomes. Its use has not been recommended in acute suspected malignant colonic obstruction as a bridge to surgery due to evidence of its impact on recurrence rates; however there is enough evidence to suggest its use as a palliation. In patients with multiple co-morbidities with high American Society of Anaesthesiologists grades, colonic stent may be considered as an alternative option to emergency surgical procedure as a bridge.